UpdatesScheme of Arrangement

Sequent's amalgamation scheme is effective.

Sequent Scientific Limited logo
Sequent Scientific LimitedSEQUENT · Filed with the exchange

The board allotted 18.19 Cr shares and 2.03 Cr warrants, receiving 92.52 Cr upfront.

Paid-up capital is now 87.21 Cr.

Dr. Haribabu Bodepudi appointed MD & Group CEO, and Ramakant Singani as new CFO.

Read the original filing(PDF)

No comments yet. Be the first.

More from Sequent Scientific Limited

All announcements